Edit

Battelle Ventures

https://www.battelleventures.com
Last activity: 18.12.2012
Active
See relevant content for battelleventures.com
Mentions
10
Investment Type: Venture Capital

Mentions in press and media 10

DateTitleDescription
18.12.2012Proterro Closes $3.5M FinancingProterro, Inc., an Ewing, NJ-based company making sugar instead of extracting it from crops, closed a $3.5m financing. The round was led by existing investor Braemar Energy Ventures, with participation from new investors Cultivian Ventures ...
06.08.2012Minimally invasive heart surgery device gets follow-on investment from Pa. economic development agencyIn addition to Ben Franklin Technology Partners of Northeastern Pennsylvania, other investors have included Life Sciences Greenhouse of Central Pennsylvania, Battelle Ventures and New Hope Ventures. The device is applied to the myocardium b...
16.07.2012Migraine patch application resubmitted for FDA approvalJane Hollingsworth, NuPathe’s CEO, said she expects a six-month review by the FDA. “With the additional data and enhancements made to the patch, we have submitted a strong application and have an even more attractive commercial opportunity ...
10.05.2012Minimally invasive cardiac surgery closure device to cut recovery timesMicro Interventional Devices’ lead device, Permaseal ,uses a sutureless technology to repair the access point of the procedure and closes using a combination of soft tissue anchors and biocompatible elastomers that produce a web structure a...
15.11.2011NuPathe to resubmit migraine patch for approval in 2012Migraine headaches affect about 31 million adults in the United States. Symptoms include moderate to severe headache pain, nausea and vomiting, photophobia, or abnormal sensitivity to light, and phonophobia, or abnormal sensitivity to sound...
18.09.2009Friday Q&A: Jane Hollingsworth of NuPathe on Zelrix, migraines and moreUpdated 9/18/09 @ 2:42 p.m. Name in title When Jane Hollingsworth takes a pill to help fight a headache, she might get nauseous or sicker still. More than half of American adults suffer similarly, she says, which is a bear of a nuisance for...
-NuPathe to resubmit migraine patch for approval in 2012NuPathe (NASDAQ: PATH) said it will resubmit a new drug application for its transdermal migraine patch for approval by the U.S. Food and Drug Administration after receiving a complete response letter from the regulator, according to the com...
-Minimally invasive heart surgery device gets follow-on investment from Pa. economic development agencyA company with a suture-less closure device for heart surgery procedures intended to reduce blood loss and the amount of time the patient spends on the operating table has received follow-on investment from Ben Franklin Technology Partners ...
-Migraine patch application resubmitted for FDA approvalNuPathe (NASDAQ:PATH), a biopharmaceutical company, has resubmitted a new drug application for its migraine patch to the U.S. Food and Drug Administration after resolving issues raised in a complete response letter last year. The Zelrix tra...
-Minimally invasive cardiac surgery closure device to cut recovery timesAs the trend toward minimally invasive cardiac surgery grows, a cardiac medical device startup has developed a sutureless closure device to facilitate transcatheter aortic valve implantation that could cut recovery times and reduce hospital...

Reviews 0

Sign up to leave a review

Sign up Log In